285 related articles for article (PubMed ID: 24449581)
1. Toll-like receptor 7-stimulated tumor necrosis factor α causes bone marrow damage in systemic lupus erythematosus.
Zhuang H; Han S; Xu Y; Li Y; Wang H; Yang LJ; Reeves WH
Arthritis Rheumatol; 2014 Jan; 66(1):140-51. PubMed ID: 24449581
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of tumor necrosis factor α antagonist-induced lupus in a murine model.
Xu Y; Zhuang H; Han S; Liu C; Wang H; Mathews CE; Massini J; Yang L; Reeves WH
Arthritis Rheumatol; 2015 Jan; 67(1):225-37. PubMed ID: 25252121
[TBL] [Abstract][Full Text] [Related]
3. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
[TBL] [Abstract][Full Text] [Related]
4. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.
Wang Y; Ewart D; Crabtree JN; Yamamoto A; Baechler EC; Fazeli P; Peterson EJ
Arthritis Rheumatol; 2015 Sep; 67(9):2403-14. PubMed ID: 26018863
[TBL] [Abstract][Full Text] [Related]
5. Heightened TLR7/9-Induced IL-10 and CXCL13 Production with Dysregulated NF-ҝB Activation in CD11c
Yim LY; Lau CS; Chan VS
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546763
[TBL] [Abstract][Full Text] [Related]
6. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis.
Savarese E; Steinberg C; Pawar RD; Reindl W; Akira S; Anders HJ; Krug A
Arthritis Rheum; 2008 Apr; 58(4):1107-15. PubMed ID: 18383384
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus.
Urbonaviciute V; Starke C; Pirschel W; Pohle S; Frey S; Daniel C; Amann K; Schett G; Herrmann M; Voll RE
Arthritis Rheum; 2013 Jun; 65(6):1612-23. PubMed ID: 23450347
[TBL] [Abstract][Full Text] [Related]
8. Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus.
Thibault DL; Graham KL; Lee LY; Balboni I; Hertzog PJ; Utz PJ
Arthritis Res Ther; 2009; 11(4):R112. PubMed ID: 19624844
[TBL] [Abstract][Full Text] [Related]
9. Dosage of X-linked Toll-like receptor 8 determines gender differences in the development of systemic lupus erythematosus.
Umiker BR; Andersson S; Fernandez L; Korgaokar P; Larbi A; Pilichowska M; Weinkauf CC; Wortis HH; Kearney JF; Imanishi-Kari T
Eur J Immunol; 2014 May; 44(5):1503-16. PubMed ID: 24500834
[TBL] [Abstract][Full Text] [Related]
10. Cutting Edge: BCAP Promotes Lupus-like Disease and TLR-Mediated Type I IFN Induction in Plasmacytoid Dendritic Cells.
Chu T; Ni M; Chen C; Akilesh S; Hamerman JA
J Immunol; 2019 May; 202(9):2529-2534. PubMed ID: 30936294
[TBL] [Abstract][Full Text] [Related]
11. TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus.
Lee PY; Kumagai Y; Li Y; Takeuchi O; Yoshida H; Weinstein J; Kellner ES; Nacionales D; Barker T; Kelly-Scumpia K; van Rooijen N; Kumar H; Kawai T; Satoh M; Akira S; Reeves WH
J Exp Med; 2008 Dec; 205(13):2995-3006. PubMed ID: 19047436
[TBL] [Abstract][Full Text] [Related]
12. A Novel Mechanism for Generating the Interferon Signature in Lupus: Opsonization of Dead Cells by Complement and IgM.
Zhuang H; Han S; Li Y; Kienhöfer D; Lee P; Shumyak S; Meyerholz R; Rosadzinski K; Rosner D; Chan A; Xu Y; Segal M; Sobel E; Yang LJ; Hoffmann MH; Reeves WH
Arthritis Rheumatol; 2016 Dec; 68(12):2917-2928. PubMed ID: 27274010
[TBL] [Abstract][Full Text] [Related]
13. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
Tada Y; Kondo S; Aoki S; Koarada S; Inoue H; Suematsu R; Ohta A; Mak TW; Nagasawa K
Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501
[TBL] [Abstract][Full Text] [Related]
14. Pleiotropic IFN-dependent and -independent effects of IRF5 on the pathogenesis of experimental lupus.
Xu Y; Lee PY; Li Y; Liu C; Zhuang H; Han S; Nacionales DC; Weinstein J; Mathews CE; Moldawer LL; Li SW; Satoh M; Yang LJ; Reeves WH
J Immunol; 2012 Apr; 188(8):4113-21. PubMed ID: 22422888
[TBL] [Abstract][Full Text] [Related]
15. Maintenance of autoantibody production in pristane-induced murine lupus.
Han S; Zhuang H; Xu Y; Lee P; Li Y; Wilson JC; Vidal O; Choi HS; Sun Y; Yang LJ; Reeves WH
Arthritis Res Ther; 2015 Dec; 17():384. PubMed ID: 26717913
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus.
Palanichamy A; Bauer JW; Yalavarthi S; Meednu N; Barnard J; Owen T; Cistrone C; Bird A; Rabinovich A; Nevarez S; Knight JS; Dedrick R; Rosenberg A; Wei C; Rangel-Moreno J; Liesveld J; Sanz I; Baechler E; Kaplan MJ; Anolik JH
J Immunol; 2014 Feb; 192(3):906-18. PubMed ID: 24379124
[TBL] [Abstract][Full Text] [Related]
17. IgE Inhibits Toll-like Receptor 7- and Toll-like Receptor 9-Mediated Expression of Interferon-α by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.
Khoryati L; Augusto JF; Shipley E; Contin-Bordes C; Douchet I; Mitrovic S; Truchetet ME; Lazaro E; Duffau P; Couzi L; Jacquemin C; Barnetche T; Vacher P; Schaeverbeke T; Blanco P; Richez C;
Arthritis Rheumatol; 2016 Sep; 68(9):2221-31. PubMed ID: 26991804
[TBL] [Abstract][Full Text] [Related]
18. Milk fat globule-EGF factor 8 suppresses the aberrant immune response of systemic lupus erythematosus-derived neutrophils and associated tissue damage.
Huang W; Wu J; Yang H; Xiong Y; Jiang R; Cui T; Ye D
Cell Death Differ; 2017 Feb; 24(2):263-275. PubMed ID: 27768123
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 8 deletion accelerates autoimmunity in a mouse model of lupus through a Toll-like receptor 7-dependent mechanism.
Tran NL; Manzin-Lorenzi C; Santiago-Raber ML
Immunology; 2015 May; 145(1):60-70. PubMed ID: 25424423
[TBL] [Abstract][Full Text] [Related]
20. Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers.
Figgett WA; Deliyanti D; Fairfax KA; Quah PS; Wilkinson-Berka JL; Mackay F
J Autoimmun; 2015 Jul; 61():9-16. PubMed ID: 26027434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
